VRCA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Verrica Pharmaceuticals Inc (VRCA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators are bearish, there are no significant trading signals, and the financial performance shows mixed results with strong revenue growth but declining net income and EPS. Without positive news catalysts or strong institutional or insider activity, it is better to hold off on investing in this stock right now.
The technical indicators for VRCA are bearish. The MACD is negative and expanding downward, RSI is neutral at 21.124, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the next support at 3.976.
The company's revenue increased significantly in the latest quarter (2025/Q4), up 1380.23% YoY.
Net income dropped by -50.17% YoY, EPS declined by -76.25% YoY, and gross margin fell by -188.74% YoY. Additionally, there is no recent news or significant insider/hedge fund activity to support a bullish sentiment.
In 2025/Q4, revenue increased to $5,092,000 (up 1380.23% YoY), but net income dropped to -$8,074,000 (down -50.17% YoY). EPS declined to -0.57 (down -76.25% YoY), and gross margin dropped to 72.49 (down -188.74% YoY).
No recent analyst ratings or price target changes are available for VRCA.
